Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

A Decade of Empirical Research on Research Integrity: What Have We (Not) Looked At?

Aubert Bonn N, Pinxten W.

J Empir Res Hum Res Ethics. 2019 Oct;14(4):338-352. doi: 10.1177/1556264619858534. Epub 2019 Jul 30.

PMID:
31359820
2.

Ethical Considerations for Movement Mapping to Identify Disease Transmission Hotspots.

de Jong BC, Gaye BM, Luyten J, van Buitenen B, André E, Meehan CJ, O'Siochain C, Tomsu K, Urbain J, Grietens KP, Njue M, Pinxten W, Gehre F, Nyan O, Buvé A, Roca A, Ravinetto R, Antonio M.

Emerg Infect Dis. 2019 Jul;25(7). doi: 10.3201/eid2507.181421.

3.

Excellent reliability and validity of the Addiction Medicine Training Need Assessment Scale across four countries.

Pinxten WJL, Fitriana E, De Jong C, Klimas J, Tobin H, Barry T, Cullen W, Jokubonis D, Mazaliauskiene R, Iskandar S, Raya RP, Schellekens A.

J Subst Abuse Treat. 2019 Apr;99:61-66. doi: 10.1016/j.jsat.2019.01.009. Epub 2019 Jan 14.

PMID:
30797395
4.

Quality of medicines in resource-limited settings: need for ethical guidance.

Ravinetto R, Pinxten W, Rägo L.

Glob Bioeth. 2018 Sep 18;29(1):81-94. doi: 10.1080/11287462.2018.1522991. eCollection 2018.

5.

Perspective: Consideration of Values When Setting Priorities in Nutrition Research: Guidance for Transparency.

Hawwash D, Pinxten W, Bonn NA, Verstraeten R, Kolsteren P, Lachat C.

Adv Nutr. 2018 Nov 1;9(6):671-687. doi: 10.1093/advances/nmy039.

6.

Measuring states of pathological (un)consciousness: research dimensions, clinical applications, and ethics.

Demertzi A, Sitt JD, Sarasso S, Pinxten W.

Neurosci Conscious. 2017 May 15;2017(1):nix010. doi: 10.1093/nc/nix010. eCollection 2017.

7.

Ethical framework for the detection, management and communication of incidental findings in imaging studies, building on an interview study of researchers' practices and perspectives.

Bunnik EM, van Bodegom L, Pinxten W, de Beaufort ID, Vernooij MW.

BMC Med Ethics. 2017 Feb 6;18(1):10. doi: 10.1186/s12910-017-0168-y.

8.

Recontacting Pediatric Research Participants for Consent When They Reach the Age of Majority.

Knoppers BM, Sénécal K, Boisjoli J, Borry P, Cornel MC, Fernandez CV, Grewal J, Holm IA, Nelson E, Pinxten W, Shabani M, Tassé AM, Zawati M, Clayton W.

IRB. 2016 Nov-Dec;38(6):1-9.

PMID:
30088377
9.

Content Analysis of Informed Consent for Whole Genome Sequencing Offered by Direct-to-Consumer Genetic Testing Companies.

Niemiec E, Borry P, Pinxten W, Howard HC.

Hum Mutat. 2016 Dec;37(12):1248-1256. doi: 10.1002/humu.23122. Epub 2016 Oct 5.

PMID:
27647801
10.

Barriers in the Uptake and Delivery of Preconception Care: Exploring the Views of Care Providers.

M'hamdi HI, van Voorst SF, Pinxten W, Hilhorst MT, Steegers EA.

Matern Child Health J. 2017 Jan;21(1):21-28. doi: 10.1007/s10995-016-2089-7.

11.

Never Look a Gift Horse in the Mouth? Four Reasons Not to Blur the Line Between Research and Care in Low- and Middle-Income Countries.

Pinxten W, Ravinetto R, Buvé A.

Am J Bioeth. 2016 Jun;16(6):17-9. doi: 10.1080/15265161.2016.1170244. No abstract available.

PMID:
27216092
12.

Risks in a Trial of an Innovative Treatment of Duchenne Muscular Dystrophy.

Bos W, Westra AE, Pinxten W, Mayer MP, Lantos JD.

Pediatrics. 2015 Dec;136(6):1173-7. doi: 10.1542/peds.2015-1589. Epub 2015 Nov 9.

13.

Gender Differences in the Development of Sexual Excitation and Inhibition Through the Life Course: Preliminary Findings from a Representative Study in Flanders.

Pinxten W, Lievens J.

J Sex Res. 2016 Sep;53(7):825-35. doi: 10.1080/00224499.2015.1063575. Epub 2015 Oct 21.

PMID:
26488561
14.

A qualitative study to evaluate strategies for changes in the assistive technology service delivery in Flanders.

Verbrugghe J, Cardinaels L, Haesen M, Schouten B, Ceccarelli B, Pinxten W, Spooren A, Timmermans A.

Stud Health Technol Inform. 2015;217:626-32. No abstract available.

PMID:
26294539
15.
16.

Ethical issues raised by whole genome sequencing.

Pinxten W, Howard HC.

Best Pract Res Clin Gastroenterol. 2014 Apr;28(2):269-79. doi: 10.1016/j.bpg.2014.02.004. Epub 2014 Mar 12. Review.

PMID:
24810188
17.

An Exploratory Study of Factors Associated With Sexual Inhibition and Excitation: Findings From a Representative Survey in Flanders.

Pinxten W, Lievens J.

J Sex Res. 2015;52(6):679-89. doi: 10.1080/00224499.2014.882880. Epub 2014 Mar 26.

PMID:
24670220
18.

Developing a sustainable nutrition research agenda in sub-Saharan Africa--findings from the SUNRAY project.

Lachat C, Nago E, Roberfroid D, Holdsworth M, Smit K, Kinabo J, Pinxten W, Kruger A, Kolsteren P.

PLoS Med. 2014 Jan 28;11(1):e1001593. doi: 10.1371/journal.pmed.1001593. eCollection 2014 Jan. No abstract available.

19.

Ethical, legal and social implications of rare diseases and orphan drugs in Europe: meeting report of a Brocher symposium.

Picavet E, Cassiman D, Pinxten W, Simoens S.

Expert Rev Pharmacoecon Outcomes Res. 2013 Oct;13(5):571-3. doi: 10.1586/14737167.2013.832626.

PMID:
24138643
20.

HIV-related knowledge and attitudes among Indonesian prison officers.

Hinduan ZR, Suherman H, Pinxten WJ, Alisjahbana B, Hospers HJ.

Int J Prison Health. 2013;9(2):92-102. doi: 10.1108/17449201311326961.

PMID:
25758441
21.

Ethical aspects of clinical research with minors.

Bos W, Tromp K, Tibboel D, Pinxten W.

Eur J Pediatr. 2013 Jul;172(7):859-66. doi: 10.1007/s00431-012-1856-8. Epub 2012 Oct 17. Review.

PMID:
23073901
22.

A fair share for the orphans: ethical guidelines for a fair distribution of resources within the bounds of the 10-year-old European Orphan Drug Regulation.

Pinxten W, Denier Y, Dooms M, Cassiman JJ, Dierickx K.

J Med Ethics. 2012 Mar;38(3):148-53. doi: 10.1136/medethics-2011-100094. Epub 2011 Sep 24.

PMID:
21947805
23.

Diversified harmony: supranational and domestic regulation of pediatric clinical trials in the European Union.

Pinxten W, Dierickx K, Nys H.

J Cyst Fibros. 2011 Jun;10 Suppl 2:S183-98. doi: 10.1016/S1569-1993(11)60022-2. Review.

24.

Developing a competence-based addiction medicine curriculum in Indonesia: the training needs assessment.

Pinxten WJ, De Jong C, Hidayat T, Istiqomah AN, Achmad YM, Raya RP, Norviatin D, Siregar IM.

Subst Abus. 2011 Apr;32(2):101-7. doi: 10.1080/08897077.2011.555710.

PMID:
21534131
25.

Access to investigational medicinal products for minors in Europe: ethical and regulatory issues in negotiating children's access to investigational medicines.

Pinxten W, Nys H, Dierickx K.

J Med Ethics. 2010 Dec;36(12):791-4. doi: 10.1136/jme.2010.036442. Epub 2010 Sep 18.

PMID:
20852303
26.

Frontline ethical issues in pediatric clinical research: ethical and regulatory aspects of seven current bottlenecks in pediatric clinical research.

Pinxten W, Nys H, Dierickx K.

Eur J Pediatr. 2010 Dec;169(12):1541-8. doi: 10.1007/s00431-010-1268-6. Epub 2010 Jul 29.

PMID:
20669029
27.

Ethical principles and legal requirements for pediatric research in the EU: an analysis of the European normative and legal framework surrounding pediatric clinical trials.

Pinxten W, Dierickx K, Nys H.

Eur J Pediatr. 2009 Oct;168(10):1225-34. doi: 10.1007/s00431-008-0915-7. Epub 2009 Jan 14.

PMID:
19142660
28.

Ethical and regulatory issues in pediatric research supporting the non-clinical application of fMR imaging.

Pinxten W, Nys H, Dierickx K.

Am J Bioeth. 2009 Jan;9(1):21-3. doi: 10.1080/15265160802627018. No abstract available.

PMID:
19132614
29.

The implementation of Directive 2001/20/EC into Belgian law and the specific provisions on pediatric research.

Pinxten W, Dierickx K, Nys H.

Eur J Health Law. 2008 Jul;15(2):153-61.

PMID:
18988594
30.

Regulating trust in pediatric clinical trials.

Pinxten W, Nys H, Dierickx K.

Med Health Care Philos. 2008 Dec;11(4):439-44. doi: 10.1007/s11019-008-9157-8. Epub 2008 Jul 18.

PMID:
18636344

Supplemental Content

Loading ...
Support Center